TABLE 2.
Disease enriched analysis associated to p-miRs modulated genes (DAVID tool).
Disease | n. genes | p Value | Bonferroni | Benjamini | |
1 | HIV | 29 | 2.14E − 16 | 4.13E − 13 | 1.38E − 13 |
2 | Asthma | 25 | 6.06E − 09 | 1.17E − 04 | 2.92E − 05 |
3 | Cell lymphoblastic leukemia-lymphoma | 22 | 1.73E − 06 | 3.33E − 03 | 6.67E − 04 |
4 | Meningeal neoplasms/meningioma | 22 | 2.35E − 06 | 4.53E − 02 | 7.54E − 04 |
5 | Hyperreactivity/hypersensitivity, immediate | 17 | 1.99E − 04 | 3.84E − 02 | 5.49E − 03 |
6 | Lung cancer | 28 | 4.30E − 04 | 8.29E − 02 | 1.04E − 01 |
7 | Multiple sclerosis | 28 | 9.09E − 05 | 1.75E + 01 | 1.95E − 01 |
8 | Chronic obstructive pulmonary disease | 24 | 1.30E − 01 | 2.51E + 02 | 2.28E − 03 |
9 | Chorioamnionitis/fetal membranes, premature rupture | 16 | 5.63E − 02 | 2.14E + 02 | 1.79E + 01 |
10 | Premature/pre-eclampsia/premature birth | 18 | 1.21E + 00 | 2.14E + 02 | 1.64E + 02 |
11 | Lymphoma, large B-cell, diffuse | 13 | 1.24E − 01 | 2.14E + 02 | 1.53E + 01 |
12 | Tuberculosis | 15 | 1.67E + 00 | 4.28E + 02 | 2.85E + 01 |
13 | Hematologic/premature birth/skin diseases | 16 | 1.97E + 00 | 4.28E + 02 | 2.68E + 02 |
14 | Inflammation/premature birth | 16 | 1.97E + 00 | 4.28E + 02 | 2.68E + 02 |
15 | Rupture/infection of amniotic sac and membranes | 17 | 2.68E + 01 | 5.14E + 03 | 3.02E + 03 |
16 | Bladder cancer | 24 | 2.91E − 01 | 5.57E + 02 | 3.09E + 02 |
17 | Diabetes, type 1 | 17 | 3.71E + 00 | 7.07E + 03 | 3.72E + 03 |
18 | Hypersensitivity | 11 | 3.82E + 00 | 7.28E + 03 | 3.64E + 03 |
19 | Infection/inflammation/premature birth | 15 | 4.26E − 01 | 8.14E + 03 | 3.88E + 03 |